NLARx Newsletter Header
NLARx News
 January 14, 2010
In This Issue
Save the Date!
NLARx News
In the States
Outrage of the Week
Health Reform
Prices & Access
Fraud & Abuse
Conflicts of Interest
Patents & Generics
Reimportation
Advertising & Marketing
Pharma Watch
PBM Watch
Medicare & Medicaid
Safety & Clinical Trials
Quick Links
Join Our Mailing List
Save the Date
NLARx Winter Meeting, Washington DC, February 26. Details and registration here.
Newsletter: Starting today, we are publishing every other Thursday.
NLARx News
NLARx Applauds GAO Report on Extraordinary Price Increases:Brand-Name Prescription Drug Pricing more
NLARx Signs Letter Urging Including PBM Transparency in Health Reform more
NLARx Joins Consumer Groups to Support  Comprehensive Sunshine Provisions  more
Report: State Medicaid Programs Lead Way Negotiating Drug Prices more
In the States
MAINE: Online Privacy Proposal Makes Second Appearance  more
Text of Maine Act to Protect Minors From Pharmaceutical Marketing more
Two Legislative Committees Consider Bills Further Regulating PBMs more
NEW HAMPSHIRE: New Hampshire's Law to Restrict Data Mining by Pharmaceutical Sales more
TEXAS: CVS Caremark Renewed as Drug Manager for Retired Teachers more
Outrage of the Week
How A Bone Disease Grew To Fit The Prescription more
Pharmaceuticals and Health Reform
NCPA Offers Updated Health Care Reform Recommendations more
House-Senate Health Care Conference Targets PhRMA Deal more
Biotech Bailout in Senate Bill more
Conn. sues Health Net over security breach more
Prices and Access to Health Care
AIDS Group Plans To Protest Merck Presentation more
Report: Prices of Some Drugs Have Doubled more
Large Price Jumps Reported for Small but Vital Drugs more
Which Drugs Have The Biggest Pre-Tax Margins? more
Pfizer: Playing At The No-Limit Table more
Fraud and Abuse
Peter Rost Gets A Little Help From The Government more
Abbott Pays $22.5M To States Over TriCor more
Schering Settles Drug Pricing Case for $21.3 Million more
As Budgets Squeeze, States Seek Federal Help With Medicaid Responsibilities more
Conflicts of Interest
Using a Pfizer Grant, Courses Aim to Avoid Bias more
Harvard Hospitals Sharply Limit Pharma Pay more
Patents and Generics
EU Demands Details on 'Pay-for-Delay' Deals  more
Will Teva join Big Pharma by 2015? more
AstraZeneca, Teva Settle Patent Dispute more
A Case That May Reshape Patent Law more
Reimportation
Drug-Import Program: In Like a Lion, Out Like a Lamb more
Advertising and Marketing
Former Amgen Rep Stymied By Arbitration more
Appeals Court Rejects Effort to Sell Medicare Physician Claims Data more
A Drug's Second Act: Battling Jet Lag more
'Salami Slicing' Promoted Lilly's Cymbalta more
Health Plan Loses in Suit Faulting Eli Lilly's Zyprexa Marketing more
Call Big Pharma a DTC conservative more
FDA warns Lilly, Bayer on improper promos more
Pharma Watch
Pfizer Jury Said to Set Prempro Punitive Damages at $8 Million more
AstraZeneca Sharpens Focus on Ethics more
Matthew Herper And Robert Langreth On The Pharmaceutical Industry more
SEC Files Insider Trading Suit Against Drug Exec more
Glaxo Finances Documentary Film About Eating more
Pfizer Doesn't Want You to See This Video more
PBM Watch
New CVS Building in Portland Sparks Worker Protest more
Express Scripts Hits 52-Week High more
PBMs and Rising Drug Costs for Federal Workers more
CVS to Boost Sales by Offering Genetic Testing more
Mandatory Mail-Order Jeopardizes Pharmacy Patients more
CVS Caremark Renewed as Drug Manager for Retired Teachers more
CVS CEO Expresses Confidence About Pharmacy-Benefits Arm more
Medicare and Medicaid
The Lessons of Medicare Part D more
$21.3 Million Medi-Cal Fraud Suit with Settled with Schering-Plough more
As Budgets Squeeze, States Seek More Help With Medicaid Responsibilities more
Safety and Clinical Trials
FDA Review Info Unavailable For Popular Drugs more
FDA to Review Anemia Drug Safety Again  more
Study Undermines Case For Antidepressants more
The High Price of FDA Approval more
FDA Aims for Transparency With New Web Site more